These findings raise the possibility of using IL-1β as a non-specific inflammatory marker of underlying immune activation, potentially aiding in the early detecting of COPD and CVD risk in YWH as they age, particularly among those with a history of tobacco use. This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.